Compliance Certificate Under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, for the Quarter ended on 31st March,2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd has filed a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The company's Registrar and Transfer Agent, MUFG Intime India Private Limited, confirmed that all securities received for dematerialization during the quarter were properly processed, confirmed or rejected, and certificates were mutilated and cancelled. The depositories were substituted as registered owners in the register of members within the prescribed timelines. This is a standard procedural filing mandated by SEBI for all listed companies and contains no material financial information or new developments.
No direct impact on shareholders or stock price. This is a routine regulatory compliance filing that confirms the company followed proper procedures for handling share dematerialization requests during the quarter.